SCHEMBL1132092

SCHEMBL1132092

CC(C)(C)c1ccc(OP(Oc2ccc(C(C)(C)C)cc2C(C)(C)C)c2ccc(-c3ccccc3)cc2)c(C(C)(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
KIF11 P52732 4/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B2 P37059 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
DHODH Q02127 1/20 0.32
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
ALDH1A1 P00352 2/20 0.31
NPC1 O15118 1/20 0.31
PLA2G1B P04054 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7615609 0.96 APEX1 (0.34) APEX1RXRARXRBKIF11CYP2C9
SCHEMBL205802 0.94 CA1 (0.35) APEX1RXRARXRBKIF11CYP2C19
SCHEMBL29355846 0.94 CA1 (0.35) APEX1RXRARXRBKIF11CYP2C19
SCHEMBL21018012 0.91 APEX1 (0.32) APEX1RXRARXRB
SCHEMBL31556870 0.91 APEX1 (0.39) APEX1KIF11CYP2C9CYP2C19CYP1A2
SCHEMBL7115234 0.91 APEX1 (0.39) APEX1KIF11CYP2C9CYP2C19CYP1A2
SCHEMBL12152002 0.91 KIF11 (0.37) APEX1RXRARXRBKIF11CA1
SCHEMBL20117923 0.90 APEX1 (0.36) APEX1RXRARXRBCYP2C9CYP2C19
SCHEMBL9402856 0.90 RXRA (0.37) APEX1RXRARXRBKIF11CYP2C9
SCHEMBL7621153 0.90 CA1 (0.33) APEX1KIF11CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144714-A1 KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2026-05-28 US disclosed
WO-2026100296-A1 FLAME-RETARDANT AROMATIC POLYCARBONATE RESIN MASTER BATCH AND METHOD FOR MANUFACTURING SAME 信越化学工業株式会社 2026-05-15 WO disclosed
US-20260092167-A1 AROMATIC POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF TEIJIN LIMITED (JP) 2026-04-02 US disclosed
US-12570593-B2 Triarylmethane compounds MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-03-10 US disclosed
EP-4046984-B1 COMPOUND, RESIN, POLYCARBONATE RESIN, AND OPTICAL MOLDED BODY MITSUI CHEMICALS INC (JP) 2025-09-03 EP disclosed
US-20250263363-A1 OLIGOMERIC BINAPHTYL COMPOUNDS AND THERMOPLASTIC RESINS MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-08-21 US disclosed
EP-4594286-A1 OLIGOMERIC BINAPHTYL COMPOUNDS AND THERMOPLASTIC RESINS MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-08-06 EP disclosed
EP-4592353-A1 AROMATIC POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF Teijin Limited (JP) 2025-07-30 EP disclosed
US-20250223282-A1 ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR POLYMERIZATION INITIATION, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2025-07-10 US disclosed
US-20250213436-A1 POLYMERIZATION ACCELERATOR, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2025-07-03 US disclosed
US-7255814-B2 Flame retardant and stabilizer combined for thermoplastics polymers CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2007-08-14 US disclosed
US-20070155871-A1 4,4'-Biphenol polysulfone compositions, process to prepare them, and articles made thereof SOLVAY ADVANCED POLYMERS, LLC (US) 2007-07-05 US disclosed
US-20070155871-A1 4,4'-Biphenol polysulfone compositions, process to prepare them, and articles made thereof SOLVAY ADVANCED POLYMERS, LLC (US) 2007-07-05 US disclosed
US-20070123692-A1 POLYSULFONE COMPOSITIONS EXHIBITING VERY LOW COLOR AND HIGH LIGHT TRANSMITTANCE PROPERTIES AND ARTICLES MADE THEREFROM SOLVAY ADVANCED POLYMERS, LLC (US) 2007-05-31 US disclosed
US-20070123692-A1 POLYSULFONE COMPOSITIONS EXHIBITING VERY LOW COLOR AND HIGH LIGHT TRANSMITTANCE PROPERTIES AND ARTICLES MADE THEREFROM SOLVAY ADVANCED POLYMERS, LLC (US) 2007-05-31 US disclosed
US-7169702-B2 Polysulfone compositions exhibiting very low color and high light transmittance properties and articles made therefrom SOLVAY ADVANCED POLYMERS, L.L.C. (US) 2007-01-30 US disclosed
US-7169702-B2 Polysulfone compositions exhibiting very low color and high light transmittance properties and articles made therefrom SOLVAY ADVANCED POLYMERS, L.L.C. (US) 2007-01-30 US disclosed
US-6437164-B1 REACTING BIPHENYL AND PHOSPHORUS TRICHLORIDE IN PRESENCE OF ALUMINUM CHLORIDE, ADDING PYRIDINE, RESULTING DICHLOROPHOSPHINE IS REACTED WITH A PHENOL, REMOVING FORMED PYRIDINE-ALUMINUM CHLORIDE COMPLEX YOSHITOMI FINE CHEMICALS, LTD. (JP) 2002-08-20 US disclosed
EP-1142898-A1 PROCESS FOR THE PREPARATION OF PHOSPHONITE COMPOUNDS Yoshitomi Fine Chemicals, Ltd. (JP) 2001-10-10 EP disclosed
US-5298541-A Molding materials HOECHST AKTIENGESELLSCHAFT (DE) 1994-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250223282-A1 ASCORBIC ACID DERIVATIVE OR SALT THEREOF, ADDITIVE FOR POLYMERIZATION INITIATION, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL PROC, THEM6, RBCK1 APEX1 1227/4885RXRA 1324/4885RXRB 2316/4885
US-20250213436-A1 POLYMERIZATION ACCELERATOR, POLYMERIZATION INITIATOR, CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL DNMT3L, CDK9, CDK6 APEX1 2106/4885RXRA 3813/4885RXRB 4168/4885
US-12570593-B2 Triarylmethane compounds CBR1, CBR3, NCOR2 APEX1 564/4885RXRA 47/4885RXRB 82/4885
US-20260144714-A1 KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL CAD, KIT, ILK APEX1 867/4885RXRA 1532/4885RXRB 1862/4885
US-20260092167-A1 AROMATIC POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF PAH, SEM1, ASH2L APEX1 1832/4885RXRA 507/4885RXRB 779/4885
US-20250263363-A1 OLIGOMERIC BINAPHTYL COMPOUNDS AND THERMOPLASTIC RESINS CBX2, CNPY2, BRIX1 APEX1 1968/4885RXRA 59/4885RXRB 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.